JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 28, 2005; DOI: 10.1124/jpet.105.095919


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.095919v1
316/2/946    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, C.-C.
Right arrow Articles by Chang, J.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuo, C.-C.
Right arrow Articles by Chang, J.-Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH


Received for publication September 21, 2005.
Revised October 26, 2005.
Accepted for publication October 27, 2005.

DNA Repair Enzyme, O6-Methylguanine DNA Methyltransferase, Modulates Cytotoxicity of Camptothecin-Derived Topoisomerase I Inhibitors

Ching-Chuan Kuo 1, Jin-Fen Liu 1, Jang-Yang Chang 1*

1 Division of Cancer Research, National Health Research Institutes

* Address correspondence to: E-mail: jychang{at}nhri.org.tw

Abstract

Two camptothecin-resistant cell lines, CPT30 and KB100, were established and characterized previously in our laboratory. Because enhanced sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and decreased expression of O6-methylguanine-DNA methyltransferase (MGMT) protein were observed in these lines, we hypothesized that MGMT may be a determinant of cytotoxicity associated with camptothecin-derived DNA topoisomerase I inhibitors (CPTs). We used the Tet-On system to induce expression of MGMT in Chinese hamster ovary (CHO) cells and RNA interference to knockdown MGMT expression in human nasopharyngeal carcinoma HONE-1 cells in order to identify any correlations between MGMT expression and CPTs cytotoxicity. CHO-derived Tet-On inducible cells (S12+) showed MGMT overexpression and statistically significant more resistance to BCNU, camptothecin, 7-ethyl-10-hydrocamptothecin (SN38), and topotecan (TPT) than parental CHO cells (p < 0.05), but there was less resistance to CPTs than to BCNU. Knockdown of MGMT expression with siRNA in HONE-1 cells conferred increased sensitivity to BCNU and CPTs compared with mock control. Furthermore, alteration of MGMT expression coincides with CPT-induced cell death and poly (ADP-ribose) polymerase (PARP) cleavage. There were no differences in protein levels and catalytic activity of topoisomerase I between MGMT-proficient and MGMT-deficient cells from the Tet-On inducible and siRNA systems. Resistance to CPTs coincided with decreased amounts of protein linked-DNA breaks generated by CPTs in MGMT-proficient cells, and vice versa in MGMT-deficient cells. Our data indicate that MGMT can modulate cytotoxicity of CPT-derived Top I inhibitors.


Key words: Camptothecin-derived topoisomerase I inhibitors, Cell death, Cytotoxicity, MGMT, PARP, Protein-linked DNA breaks


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L.-C. Ma, C.-C. Kuo, J.-F. Liu, L.-T. Chen, and J.-Y. Chang
Transcriptional Repression of O6-Methylguanine DNA Methyltransferase Gene Rendering Cells Hypersensitive to N,N'-Bis(2-chloroethyl)-N-nitrosurea in Camptothecin-Resistant Cells
Mol. Pharmacol., August 1, 2008; 74(2): 517 - 526.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
B. Verbeek, T. D. Southgate, D. E. Gilham, and G. P. Margison
O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy
Br. Med. Bull., March 1, 2008; 85(1): 17 - 33.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.